Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for Depression Following Traumatic Brain Injury
NCT00254007Phase 4Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jul 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of citalopram in major depressive disorder (MDD), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Hamilton Depression Rating Scale at 10 weeks. Started Jul 2003; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00254007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254007.